文献速递药物不良反应与药物警戒

基于机器学习的药物警戒人工智能应用范围综述

Artificial Intelligence Based on Machine Learning in Pharmacovigilance: A Scoping Review.
PubMed 文献 · Drug Saf · 2022-05-17

该范围综述检索了2000年至2021年9月的PubMed、Embase、Web of Science和IEEE Xplore数据库,经手动筛选7744篇摘要后纳入393篇论文。研究发现53%的研究使用传统统计方法检测安全信号,仅42篇(10%)反映了当前机器学习最佳实践,表明人工智能进展尚未充分渗透药物警戒领域。

要点

  • 53%的研究使用传统统计方法检测安全信号,而非机器学习。
  • 使用较新机器学习方法的研究中,61%仅对现成技术做微小修改。
  • 仅42篇(10%)研究体现当前机器学习最佳实践。

核心结论

  • 人工智能进展尚未充分渗透药物警戒领域,但近期研究显示这一情况可能正在改变。

研究设计与样本

  • 范围综述,检索PubMed、Embase、Web of Science和IEEE Xplore数据库2000年至2021年9月的文献。
  • 手动筛选7744篇摘要后纳入393篇论文,提取研究设计、数据来源、样本量和机器学习方法等关键数据。

主要发现

  • 53%的研究聚焦于使用传统统计方法检测安全信号。
  • 使用较新机器学习方法的研究中,61%使用现成技术并做微小修改。
  • 时间分析显示深度学习等较新方法近年来使用增加。
  • 仅42篇研究(10%)反映当前机器学习最佳实践和趋势。
  • 在154篇聚焦数据摄入与摄取的研究中,30篇(19%)纳入了相同的最佳实践。

关键数值与推荐

  • 定义了具有良好机器学习实践特征的研究,并手动审查识别符合这些标准且结果有前景的研究。

临床怎么用

  • 临床药学智能体医生可关注机器学习在药物警戒安全信号检测中的潜在应用,但需注意多数研究仍使用传统统计方法。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Artificial intelligence based on machine learning has made large advancements in many fields of science and medicine but its impact on pharmacovigilance is yet unclear. OBJECTIVE: The present study conducted a scoping review of the use of artificial intelligence based on machine learning to understand how it is used for pharmacovigilance tasks, characterize differences with other fields, and identify opportunities to improve pharmacovigilance through the use of machine learning. DESIGN: The PubMed, Embase, Web of Science, and IEEE Xplore databases were searched to identify articles pertaining to the use of machine learning in pharmacovigilance published from the year 2000 to September 2021. After manual screening of 7744 abstracts, a total of 393 papers met the inclusion criteria for further analysis. Extraction of key data on study design, data sources, sample size, and machine learning methodology was performed. Studies with the characteristics of good machine learning practice were defined and manual review focused on identifying studies that fulfilled these criteria and results that showed promise. RESULTS: The majority of studies (53%) were focused on detecting safety signals using traditional statistical methods. Of the studies that used more recent machine learning methods, 61% used off-the-shelf techniques with minor modifications. Temporal analysis revealed that newer methods such as deep learning have shown increased use in recent years. We found only 42 studies (10%) that reflect current best practices and trends in machine learning. In the subset of 154 papers that focused on data intake and ingestion, 30 (19%) were found to incorporate the same best practices. CONCLUSION: Advances from artificial intelligence have yet to fully penetrate pharmacovigilance, although recent studies show signs that this may be changing.

来源:Drug Saf,查看原文。版权归原作者所有。

引用

  1. Kompa B, Hakim JB, Palepu A, et al. Artificial Intelligence Based on Machine Learning in Pharmacovigilance: A Scoping Review. Drug Saf. 2022. PMID: 35579812. doi:10.1007/s40264-022-01176-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。